ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kemwell Biopharma increases capacity for manufacturing of biologics
April 28, 2021The company has acquired an Ambr 250, added three single use bioreactors (SUBs) to support process scale-up, preclinical toxicology batch and early cGMP clinical trial supplies at 250L to 1000L scale in its current facility. -
Stempeutics partners with Kemwell for global development and commercialisation of stem cell…
July 30, 2019Stempeutics Research has announced that it has signed a strategic deal with Kemwell Biopharma for global commercialisation of its stem cell product Stempeucel. -
Kemwell Biopharma supplies Biologics Drug substance
June 05, 2017Kemwell Biopharma supplies Biologics Drug Substance for Phase 1 Clinical Trials for US IND Filing
Pharma Sources Insight January 2025
